AstraZeneca Changes Its COVID-19 Vaccine Name From CoviShield To Vaxzevria Due To Blood Clots Controversy

AstraZeneca has rebranded and changed the name of its COVID-19 vaccine from CoviShield to Vaxzevria. The move is because the company is struggling to convince people that the vaccine is safe amidst the controversy that AstraZeneca COVID-19 vaccine is causing blood clots.

AstraZeneca has been struggling a lot to assure the public that its vaccine is safe. The name change doesn’t involve any alteration to the actual drug.

The firm said, its packaging and labelling may look different but...

Subscribe to view this content.

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].